Condition
Heart Failure
Heart failure means the heart cannot pump blood well enough for the body's needs, and the energy-starved muscle struggles to contract, leaving people tired, breathless and prone to fluid buildup. Coenzyme Q10 and omega-3 fatty acids have the strongest support among supplements, and small trials of coenzyme Q10 found blood flow went up. Those trials included only 23 people in total, so the evidence for that finding is limited.
Sources: PMID 16882678; PMID 17644511
- Supplements studied
- 14
- Medicines and peptides
- 2
- Graded outcomes
- 17
- Trials
- 21
- People studied
- 163,152
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure Small Improvement | Improves (the measure goes down) | Small effect | 7 studies | 65 people | ||
Studies that measured blood pressure
| ||||||
| Exercise Tolerance | Improves (the measure goes up) | 30 people | ||||
| Left Ventricular Ejection Fraction | Improves (the measure goes up) | 35 people | ||||
| Right Ventricular Ejection Fraction | Improves (the measure goes up) | 65 people | ||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Urea Nitrogen (BUN) Small Decrease | Improves (the measure goes down) | Small effect | 894 people | |||
| Kidney Function | Improves (the measure goes up) | 2 studies | 135 people | |||
Studies that measured kidney function | ||||||
| Serum Albumin | Improves (the measure goes up) | 516 people | ||||
| Uric Acid | Improves (the measure goes down) | 353 people | ||||
Taurine
- Blood Pressure: improves
- Weight: improves
- Exercise Tolerance: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure Small Improvement | Improves (the measure goes down) | Small effect | 3 studies | 29 people | ||
Studies that measured blood pressure
| ||||||
| Weight | Improves (the measure goes down) | 1 study | 29 people | |||
Studies that measured weight | ||||||
| Exercise Tolerance | Improves (the measure goes up) | 29 people | ||||
| Heart Rate | Improves (the measure goes down) | 29 people | ||||
Creatine
- Exercise Tolerance
- Subjective Well-Being: improves
Coenzyme Q10
- Blood Flow: improves
- Exercise Tolerance: improves
- Left Ventricular Ejection Fraction: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Small Increase | Improves (the measure goes up) | Small effect | 2 studies | 23 people | ||
| Exercise Tolerance | Improves (the measure goes up) | 2 studies | 89 people | |||
| Left Ventricular Ejection Fraction | Improves (the measure goes up) | 1 study | 41 people | |||
Studies that measured left ventricular ejection fraction | ||||||
| Heart Size | Changes; see studies | 41 people | ||||
| Oxygen Uptake | Improves (the measure goes up) | 23 people | ||||
| Quality of Life | Improves (the measure goes up) | 41 people | ||||
Iron
- 6-Minute Walking Test Performance: improves
- Hemoglobin: improves
- All-Cause Mortality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| 6-Minute Walking Test Performance Small Improvement | Improves (the measure goes up) | Small effect | 5,205 people | |||
| Hemoglobin | Improves (the measure goes up) | 7 studies | 748 people | |||
Studies that measured hemoglobin
| ||||||
| All-Cause Mortality | Improves (the measure goes down) | 1 study | 5,205 people | |||
| Cardiovascular Disease Mortality | Improves (the measure goes down) | 1 study | 5,205 people | |||
Studies that measured cardiovascular disease mortality | ||||||
| Exercise Capacity | Improves (the measure goes up) | 1 study | 5,205 people | |||
Studies that measured exercise capacity | ||||||
| Ferritin | Improves (the measure goes up) | 574 people | ||||
| Left Ventricular Ejection Fraction | Improves (the measure goes up) | 115 people | ||||
| Quality of Life | Improves (the measure goes up) | 5,205 people | ||||
| Risk of Hospitalization for Heart Failure | Improves (the measure goes down) | 3,378 people | ||||
D-Ribose
- Angina: improves
- ATP Regeneration: improves
- Exercise Capacity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Angina Small Improvement | Improves (the measure goes up) | Small effect | 20 people | |||
| ATP Regeneration | Improves (the measure goes up) | 2 studies | 15 people | |||
| Exercise Capacity | Improves (the measure goes up) | 2 studies | 251 people | |||
| Atrial Contribution To Left Ventricular Filling | Improves (the measure goes up) | 15 people | ||||
| Brain Natriuretic Peptide | Improves (the measure goes up) | 216 people | ||||
| E wave deceleration time | Improves (the measure goes up) | 15 people | ||||
| End-Systolic Volume | Improves (the measure goes up) | 15 people | ||||
| Exercise Tolerance | Improves (the measure goes up) | 35 people | ||||
| Glycogen Resynthesis | Improves (the measure goes up) | 15 people | ||||
| Left Atrial Dimension | Improves (the measure goes up) | 15 people | ||||
| Left Ventricular Diastolic Dimension | Improves (the measure goes up) | 15 people | ||||
| Left Ventricular Ejection Fraction | Improves (the measure goes up) | 231 people | ||||
| Quality of Life | Improves (the measure goes up) | 231 people | ||||
| Vigor/Activity | Improves (the measure goes up) | 216 people | ||||
Berberine
- Exercise Tolerance
- Quality of Life: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Exercise Tolerance No effect | NoneNo effect | 1 study | 156 people | |||
Studies that measured exercise tolerance | ||||||
| Quality of Life | Improves (the measure goes up) | 156 people | ||||
Cocoa Extract
- Heart Failure Risk
- Mitochondrial Protection: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Heart Failure Risk No effect | NoneNo effect | 1 study | 106,109 people | |||
Studies that measured heart failure risk | ||||||
| Mitochondrial Protection | Improves (the measure goes up) | 1 study | 5 people | |||
Studies that measured mitochondrial protection | ||||||
Omega-3 Fatty Acids
- Cardiovascular Disease Mortality
- Risk of Hospitalization for Heart Failure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cardiovascular Disease Mortality No effect | NoneNo effect | 1 study | 45,585 people | |||
Studies that measured cardiovascular disease mortality | ||||||
| Risk of Hospitalization for Heart Failure | Improves (the measure goes down) | 45,585 people | ||||
Thiamine (Vitamin B1)
- 6-Minute Walking Test Performance
- Left Ventricular Ejection Fraction: improves
- End-Diastolic Volume: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| 6-Minute Walking Test Performance No effect | NoneNo effect | 274 people | ||||
| Left Ventricular Ejection Fraction | Improves (the measure goes up) | 1 study | 274 people | |||
Studies that measured left ventricular ejection fraction | ||||||
| End-Diastolic Volume | Improves (the measure goes up) | 274 people | ||||
| Heart Failure Class | Improves (the measure goes up) | 274 people | ||||
| N-terminal Prohormone of Brain Natriuretic Peptide | Improves (the measure goes up) | 274 people | ||||
Nitrate
- Exercise Capacity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Exercise Capacity | Improves (the measure goes up) | 5 studies | 1,160 people | |||
Studies that measured exercise capacity
| ||||||
Vitamin C
- Heart Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Heart Rate | Improves (the measure goes down) | 1 study | 11 people |
Terminalia Arjuna
- Left Ventricular Ejection Fraction: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Left Ventricular Ejection Fraction | Improves (the measure goes up) | 1 study | 12 people |
Prescription medicines and peptides studied, for context
Nesiritide (Natrecor)
- Pulmonary Capillary Wedge Pressure: improves
- Dyspnea Improvement: improves
- Systemic Vascular Resistance: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Pulmonary Capillary Wedge Pressure Significant and sustained reduction in PCWP. VMAC trial showed greater PCWP reduction vs nitroglycerin at 3 hours (P=0.03). | Improves (the measure goes down) | Large effect | 15 studies | |||
| Dyspnea Improvement VMAC trial: Greater improvement in dyspnea vs nitroglycerin at 3 hours. Rapid onset symptomatic relief in ADHF. | Improves (the measure goes up) | Large effect | 15 studies | |||
| Systemic Vascular Resistance Balanced vasodilation with sustained SVR reduction without tachyphylaxis observed in clinical trials. | Improves (the measure goes down) | Moderate effect | 15 studies | |||
| Cardiac Output Improved cardiac output secondary to afterload reduction. Comparable efficacy to dobutamine with better safety profile. | Improves (the measure goes up) | Moderate effect | 15 studies | |||
| Global Clinical Status Improvement in global clinical status in trials, though long-term outcomes remain under study. | Improves (the measure goes up) | Moderate effect | 16 studies |
Elamipretide (Forzinity/SS-31)
- LV End-Systolic Volume (HFrEF)
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| LV End-Systolic Volume (HFrEF) PROGRESS-HF Phase 2 (n=71): Elamipretide 4mg or 40mg daily x28 days did not improve LVESV vs placebo in stable HFrEF patients. Well tolerated but failed to meet primary endpoint. | NoneNo effect | 10 studies |
Key findings
- Blood PressureImproves (the measure goes down)
- Blood Urea Nitrogen (BUN)Improves (the measure goes down)
- Exercise Tolerance
The Heart Failure protocol
2 primary supplements · 6 supporting supplements
- Coenzyme Q10100–300 mg daily (ubiquinol form preferred)
- Omega-3 Fatty Acids1–4 g EPA/DHA daily (prescription strength shown beneficial)
Shop the evidence-backed picks
Support alongside medical care. These supplements are not a treatment for Heart Failure. If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
The supplements graded A or B for Heart Failure. Each opens third-party tested products for that supplement.
- Grade B
- Grade B
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
7 studies from PubMed
- Safety, acceptance, and physiologic effects of sauna bathing in people with chronic heart failure: a pilot report.
- Beneficial effects of Waon therapy on patients with chronic heart failure: results of a prospective multicenter study.
- Effects of repeated sauna treatment on ventricular arrhythmias in patients with chronic heart failure.
- Improvement of autonomic nervous activity by Waon therapy in patients with chronic heart failure.
- Effect of Waon therapy on oxidative stress in chronic heart failure.
- Waon Therapy for Managing Chronic Heart Failure - Results From a Multicenter Prospective Randomized WAON-CHF Study.
- Neurohumoral Modulation During Waon Therapy in Chronic Heart Failure - Subanalysis of Waon-CHF Study.